Vaccines

25 Jul 2017 Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs
24 Jul 2017 Genocea Reports Positive Top-Line 12-Month Phase 2b Data for GEN-003 in Genital Herpes
24 Jul 2017 Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine
24 Jul 2017 VALNEVA Receives FDA Fast Track Designation for its Lyme Disease Vaccine Candidate VLA15
20 Jul 2017 BriaCell Provides Clinical Update on its Ongoing Phase I/IIa Clinical Study of BriaVaxTM in Advanced Breast Cancer
19 Jul 2017 Biothera Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Study Evaluating Combination of Imprime PGG and Merck’s KEYTRUDA in Non-Small Cell Lung Cancer
18 Jul 2017 AXON's Tau Vaccine Has Completed Phase II Enrolment in Alzheimer's
14 Jul 2017 Publication in Cell Demonstrates Moderna’s Zika mRNA Vaccine Prevents In Utero Transmission of Zika Virus in Mice, Protects Against Zika-Related Congenital Damage
12 Jul 2017 Meissa Vaccines awarded $1.6m Fast Track SBIR Grant to advance IND preparations for RSV vaccine candidate
06 Jul 2017 Nature Publication Reports Favorable Clinical Trial Results of BioNTech’s Individualized Cancer Vaccine IVAC® MUTANOME
06 Jul 2017 Initial Results from Dana-Farber Cancer Institute Personalized Neoantigen Vaccine Published in Nature
05 Jul 2017 Aimmune Therapeutics Enrolls First Patient in ARTEMIS (ARC010) European Phase 3 Clinical Trial of AR101 for the Treatment of Peanut Allergy
30 Jun 2017 ALK: Five-year GRAZAX® Asthma Prevention (GAP) Trial Reveals Benefits of Early Treatment Intervention in Children
27 Jun 2017 Araclon Biotech initiates phase II clinical trials of its Alzheimer's vaccine
27 Jun 2017 GSK receives CHMP positive opinion for Synflorix pneumococcal vaccine four-dose vial
27 Jun 2017 OSE Immunotherapeutics Announces Temporary Pause of Patient Accrual While Continuing Treatment for Patients Already Enrolled In Phase 3 Clinical Trial of Tedopi® in Advanced Lung Cancer
21 Jun 2017 ImmunoCellular Therapeutics Provides Update on Strategic Review and Decision to Suspend Further Patient Randomization for ICT-107 Phase 3 Trial
21 Jun 2017 GSK presents positive results from Phase III revaccination study of its candidate shingles vaccine Shingrix at CDC's Advisory Meeting
21 Jun 2017 NanoBio And Porton Biopharma Receive Approval To Advance Next Generation Anthrax Vaccine
21 Jun 2017 Genexine Receives Approval to Initiate Phase Ib/II Trial of GX-188E, HPV Therapeutic DNA Vaccine, in Combination With KEYTRUDA® (pembrolizumab), for the Treatment of HPV-Induced Cervical Cancer
21 Jun 2017 Pfizer Begins Phase 1 Clinical Trial to Evaluate Investigational Group B Streptococcus Vaccine
15 Jun 2017 Inovio Fully Enrolls 160 Subjects in Puerto Rico for Second Zika Vaccine Phase 1 Trial; Continues Leadership to Advance an Effective Preventive Solution
13 Jun 2017 Aimmune Therapeutics Reports on Up-Dosing in Its Ongoing Phase 3 PALISADE Trial of AR101 for Peanut Allergy
13 Jun 2017 Autoantigen GAD-Vaccine is Safe for Children at High Risk for Developing Type 1 Diabetes
11 Jun 2017 Inovio Begins Phase 3 Clinical Trial of VGX-3100 for the Treatment of HPV-Related Cervical Pre-Cancer

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top